B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
about
The B7 family of immune-regulatory ligandsNo evidence for dualism in function and receptors: PD-L2/B7-DC is an inhibitory regulator of human T cell activationThe PD-1 pathway in tolerance and autoimmunityConstitutive and inducible expression of b7 family of ligands by human airway epithelial cellsThe programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) miceMolecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interactionThe immunomodulatory proteins B7-DC, B7-H2, and B7-H3 are differentially expressed across gestation in the human placentaPD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cellsB7x: a widely expressed B7 family member that inhibits T cell activationProgrammed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancerMelanoma immunotherapy dominates the fieldA Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway & Translational Blockade of Immune CheckpointsImmunotherapy for lung cancerRegulation of Th2 Cell Immunity by Dendritic CellsTargeting PD-1/PD-L1 in the treatment of metastatic renal cell carcinomaImmunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigationsThe Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver DiseaseHuman Cancer Immunotherapy with PD-1/PD-L1 BlockadeRole of the PD-1 pathway in the immune responseImmunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancerNew immunotherapies targeting the PD-1 pathwayHerpesvirus exploitation of host immune inhibitory pathwaysHigh-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infectionThe PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptorsStructure and Interactions of the Human Programmed Cell Death 1 ReceptorThe blockade of immune checkpoints in cancer immunotherapySafety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerImmune checkpoint blockade: a common denominator approach to cancer therapyNivolumab in melanoma: latest evidence and clinical potentialCo-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamilyPD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis TreatmentVSIG4, a B7 family-related protein, is a negative regulator of T cell activationGeneration and characterization of B7-H4/B7S1/B7x-deficient miceBTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responsesHigh avidity cytotoxic T lymphocytes can be selected into the memory pool but they are exquisitely sensitive to functional impairmentAssociation of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapyPD-L1, PD-L2 and PD-1 expression in metastatic melanoma: Correlation with tumor-infiltrating immune cells and clinical outcome.Both PD-1 ligands protect the kidney from ischemia reperfusion injury.Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2.
P2860
Q21184159-AE78A60C-BA05-47F0-9A36-04DB16C34383Q24613354-5969A829-8F33-4A8F-BC92-C052D413FC0BQ24633549-1A183CD6-37CC-4678-8858-5D6A4BF64272Q24645109-F1D1309F-975F-4B42-AF0E-C7A1C9FD2FA6Q24670319-5AE69ABD-11DA-4187-B61A-7C892A968B8DQ24673269-C33A0E61-7656-4F4D-A855-AA08F3BFE0C1Q24675388-6A58B918-F1F2-4383-8F91-3B7DC2864F56Q24677367-39C0D3C6-3175-45EC-A95F-D339DE41CA0EQ24683252-0E6CDB95-43E0-45AA-9BAB-3F3BFEF6E40FQ24685406-7A31CA7A-99AC-4C5C-81DB-A3AA1E7C9BA3Q26738671-5AF9F79B-3C1C-483A-B37F-4046BFAC07F4Q26738729-35CE28EC-2C06-45CE-BC5F-A6AF61FAEB6FQ26751254-F24B0867-1FE8-404A-BDF2-96652053E293Q26764869-41331486-5F23-4163-B7A8-72B981994A27Q26775769-DF0D61F3-5CC2-4FF1-A9F7-3EACAFB48BCCQ26781038-0DAAFB3D-6BF2-4BD4-9EF1-9DDFCB3F3400Q26784452-5D0DB8FE-3F87-4E33-8172-4D1F0A23F3AEQ26786108-DFED071C-0DBB-4604-8DFE-A77E37D1F432Q26828748-C358D704-74BF-41AD-979A-5D73CD124A97Q26996829-6B8B9DAA-0A2A-4949-95C8-70F47A24F5A3Q27010018-CF66086A-ED14-45A7-9934-70DACD8DAD12Q27013680-0EEE71EE-3673-4581-8B7E-001953C7EB91Q27490345-2669C307-A9FC-4A35-95C8-C71B7C8845E3Q27649885-32031AA4-79F8-4A41-A940-B43AEFA82D39Q27676419-6D00017D-3104-451D-BEDF-962224837D0BQ27860852-9BB40321-B4DF-4213-BC9B-D527CD8473EFQ27860857-ADFFE95E-7B02-418B-A2AB-24F57A2F36EEQ28083981-77A12087-FE1E-4067-90F8-F16ACEF4A5B1Q28258598-6C69877D-7419-4153-A4DF-FB4BDD5DD0AFQ28271806-3193A50A-F17D-428D-AED2-62FE2E325743Q28547901-29D076BC-69E2-46FF-B208-446E0E0B045AQ28584882-675CC22D-3F90-4F36-8659-4219F9F9AA56Q28585447-1C837A57-FB7B-40D0-849A-25798BFE7ADBQ28589743-1BCDDE9A-05D6-4116-B9B0-43541D118C04Q28594992-D2F88BBE-308A-4623-942F-2375EBEDFCA9Q28729034-C52DEDFF-16CA-4FB5-B91B-D417AA1B407EQ29617774-DE2DB352-C7A5-41AF-89F6-1F45F046F331Q30275174-E6AD9E31-98D5-4697-AE87-171EB3F2F17CQ30301290-57748D21-8E70-4225-AAF0-B1E0B2D0DC22Q30515733-9873F23E-81A5-4E9C-9811-1F68060A7A4C
P2860
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
@ast
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
@en
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
@en-gb
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
@nl
type
label
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
@ast
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
@en
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
@en-gb
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
@nl
prefLabel
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
@ast
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
@en
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
@en-gb
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
@nl
P2093
P2860
P3181
P356
P1476
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
@en
P2093
D M Pardoll
H Tsuchiya
J E Slansky
P2860
P304
P3181
P356
10.1084/JEM.193.7.839
P407
P577
2001-04-02T00:00:00Z